Avazzia HVPC Bio-Electrical Stimulation Technology (BEST™) Microcurrent CTS RCT

Inclusion Criteria: * Have a prior diagnosis (Dx) of CTS and have had a trial of conservative treatment for a minimum of 4 weeks without successful results due to continuing symptoms that interfere with normal function. * Confirmation of this Dx shall include at least three findings as defined below: * Muscle atrophy, severe weakness of thenar muscles * 2-point discrimination test \>6mm * Flick sign (shaking hand) * Phalen's sign * Tinel's sign * Reverse Phalen's sign * Abnormal Katz hand diagram scores * Positive NCV testing * Age \>18 - \<70 years old * Males/Females of all ethnicities * Post-surgical failures \>6 months post op * Ability to understand the informed consent document before signing it Exclusion Criteria: * Systemic disease that would affect treatment outcome such as inflammatory joint diseases (i.e., rheumatoid arthritis, systemic lupus); malignancies undergoing treatment or any malignancies (in remission or not) with involvement of the musculoskeletal system. * Co-morbidities, thoracic outlet nerve impingement, neuropathy, etc. should be identified and, if significant, the candidate should be excluded from the study. * Cubital tunnel syndrome, anterior and posterior interosseous nerve syndrome, lateral and medial epicondylitis, handlebar palsy, De Quervain's disease, trigger finger, and Intersection syndrome should be differentiated from CTS and not included in this study. * Uncontrolled mood disorders, such as depression, anxiety. * Drug or substance abuse within past 90 days. * Any hand pathology requiring surgical intervention. * Active litigation, workers compensation * Any participant with an electrically implanted device such as a pacemaker, neural stimulator, etc. * Participant is currently pregnant, nursing, or may become pregnant.